Matches in Nanopublications for { ?s ?p "[In A375 xenografts, the antitumor effects of sorafenib and MI-319 were additive and associated with the down modulation of Bcl-2 and Bcl-xL, the nuclear translocation of AIF, and increased suppression of tumor angiogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- assertion description "[In A375 xenografts, the antitumor effects of sorafenib and MI-319 were additive and associated with the down modulation of Bcl-2 and Bcl-xL, the nuclear translocation of AIF, and increased suppression of tumor angiogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP815679.RAc3hvdtoLQPAW_lftHHSO5SSeAOv6xUYZP4yDbuf22wQ130_assertion description "[In A375 xenografts, the antitumor effects of sorafenib and MI-319 were additive and associated with the down modulation of Bcl-2 and Bcl-xL, the nuclear translocation of AIF, and increased suppression of tumor angiogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815679.RAc3hvdtoLQPAW_lftHHSO5SSeAOv6xUYZP4yDbuf22wQ130_provenance.
- NP594388.RAJ39S3h6JXC7tRES6LNmMzQiBzswDYH6IEN_QzXHbbS4130_assertion description "[In A375 xenografts, the antitumor effects of sorafenib and MI-319 were additive and associated with the down modulation of Bcl-2 and Bcl-xL, the nuclear translocation of AIF, and increased suppression of tumor angiogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP594388.RAJ39S3h6JXC7tRES6LNmMzQiBzswDYH6IEN_QzXHbbS4130_provenance.
- assertion description "[In A375 xenografts, the antitumor effects of sorafenib and MI-319 were additive and associated with the down modulation of Bcl-2 and Bcl-xL, the nuclear translocation of AIF, and increased suppression of tumor angiogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP924704.RAexXOF7Qxx2W-GS0WN3HT7HLXbXxQuM8J0ikxb7qhnX0130_assertion description "[In A375 xenografts, the antitumor effects of sorafenib and MI-319 were additive and associated with the down modulation of Bcl-2 and Bcl-xL, the nuclear translocation of AIF, and increased suppression of tumor angiogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924704.RAexXOF7Qxx2W-GS0WN3HT7HLXbXxQuM8J0ikxb7qhnX0130_provenance.
- NP263934.RA8ZQIdThN81LrYbkPn2RAtitk1QpLgh8EBVMCjn0LUcM130_assertion description "[In A375 xenografts, the antitumor effects of sorafenib and MI-319 were additive and associated with the down modulation of Bcl-2 and Bcl-xL, the nuclear translocation of AIF, and increased suppression of tumor angiogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP263934.RA8ZQIdThN81LrYbkPn2RAtitk1QpLgh8EBVMCjn0LUcM130_provenance.
- NP924707.RAO_G1yqUEw7MPlR7kXvzCVoaQwHFvufg1vkMeZlLXfws130_assertion description "[In A375 xenografts, the antitumor effects of sorafenib and MI-319 were additive and associated with the down modulation of Bcl-2 and Bcl-xL, the nuclear translocation of AIF, and increased suppression of tumor angiogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924707.RAO_G1yqUEw7MPlR7kXvzCVoaQwHFvufg1vkMeZlLXfws130_provenance.